Developing Immunoniosomes (INs): Antibody and Fab conjugations of niosomal nanoparticles via UV-NBS and EDC/NHS chemistry for treating glioblastoma cells
Antibody-conjugated nanoparticles (ACNPs), particularly immunoliposomes (ILs), have gained significant attention in cancer treatment due to their enhanced efficacy and superior tissue penetration. However, their high production costs and technical challenges underscore the need for more cost-effecti...
Saved in:
| Main Authors: | Nilufer Cakir, Hatice Oncel, Aylin Ozkan, Dilan Bicak, Sibel Akgun Bas, Nur Mustafaoglu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-12-01
|
| Series: | International Journal of Pharmaceutics: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590156725000520 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Adverse Effects and Use of Bevacizumab in Patients with Glioblastoma: A Systematic Review and Meta-Analysis
by: Alejandro Bruna-Mejías, et al.
Published: (2025-05-01) -
Niosome Preparation Techniques and Structure—An Illustrated Review
by: Saeid Mezail Mawazi, et al.
Published: (2025-01-01) -
Niosomes: an extensive analysis of its structure, preparation, and uses in drug delivery
by: Vaishali Sharma, et al.
Published: (2025-06-01) -
Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration
by: Jay Patel, et al.
Published: (2015-06-01) -
Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy
by: Hao Qian, et al.
Published: (2025-03-01)